Nanexa

Nanexa Tangible Book Value per Share

The Tangible Book Value per Share of Nanexa (NANEXA.ST) as of Nov 16, 2026 is 0.62 SEK. In the previous year, Tangible Book Value per Share was 0.07 SEK — a change of 780.73% (higher).

Tangible Book Value per Share

0.62SEK

YoY

780.73%

Last updated:

Tangible Book Value per Share of Nanexa is 2025 0.62 SEK. Tangible Book Value per Share of Nanexa was 2024 0.07 SEK. It decreases by 780.73% higher compared to the previous year.

The Nanexa Tangible Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Tangible Book Value per Share
Date
Tangible Book Value per Share
Jan 1, 2018
0.03 SEK
Jan 1, 2019
0.05 SEK
Jan 1, 2020
0.06 SEK
Jan 1, 2021
0.64 SEK
Jan 1, 2022
0.27 SEK
Jan 1, 2023
0.34 SEK
Jan 1, 2024
0.07 SEK
Jan 1, 2025
0.62 SEK
The Nanexa Tangible Book Value per Share history
YEARTangible Book Value per ShareYoY
0.62SEK+780.73%
0.07SEK-79.17%
0.34SEK+26.24%
0.27SEK-58.47%
0.64SEK+971.90%
0.06SEK+25.04%
0.05SEK+48.99%
0.03SEK-80.74%
0.17SEK+61.85%
0.10SEK+179.70%
0.04SEK+312.87%
0.01SEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanexa Stock analysis

What does Nanexa do? Nanexa AB develops and distributes medical nanotechnology products including PharmaShell, a drug delivery system for targeted dosing, and antifungal coating that protects medical products from fungal growth. The company also offers low-friction coating for peripheral venous catheters. Its products are sold to healthcare providers and medical device manufacturers seeking advanced solutions for drug delivery and infection prevention. Nanexa AB's revenue comes from the sale of its nanotechnology-based products to healthcare institutions and medical device companies. The firm focuses on life science R&D, targeting applications in pharmaceuticals and medical device manufacturing. Its product portfolio serves the healthcare sector by enhancing drug efficacy and protecting medical equipment from microbial contamination. The company's business model relies on selling specialized coatings and delivery systems to medical professionals and manufacturers. PharmaShell enables precise drug targeting, while antifungal and low-friction coatings address specific clinical needs in medical device usage. These products are designed to improve patient outcomes and reduce complications in medical treatments. Nanexa is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanexa stock

Tangible Book Value per Share of Nanexa is 0.62 SEK in 2025.

Tangible Book Value per Share of Nanexa changed from 0.07 SEK to 0.62 SEK, representing a 780.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Tangible Book Value per Share Nanexa since 2006 – with annual values, charts, and detailed analysis.

Tangible book value per share excludes intangible assets and goodwill, providing a more conservative measure of per-share net asset value.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Nanexa

All Key Metrics — Nanexa